CDMOThe CDMO partner for next-gen medicineAs advanced therapies and vaccines reshape healthcare, Wacker Biotech is emerging as a CDMO partner of choice. With decades of experience and integrated expertise spanning pDNA, RNA, LNP formulation, … more ➔
real estateWhere Life Science Scales in BaselThe Basel region is one of the world’s leading life-science clusters. Pharmaceutical companies, biotech firms and research institutions benefit from a unique combination of talent, infrastructure … more ➔
CRO & CDMOBeyond monoclonals: Multispecific antibodiesNew biologic logic – Multispecific antibodies extend targeted therapy beyond one antigen or pathway. By combining binding sites, cell recruitment and defined valencies within one molecule, they enable … more ➔
artificial intelligenceAI in clinical research: hype vs. realityAI can already reduce administrative work, improve decision-making and streamline parts of clinical development. But its impact is often overstated. Evidenze’s Raphaela Schnurbus explains where AI … more ➔
artificial intelligenceClosing AI medicine’s manufacturing gapAt the IZB in Martinsried, Invitris is developing a cell-free platform to turn digital sequences into proteins, antibodies and phages within hours. CEO Patrick Grossmann explains why AI is shifting … more ➔
CRO & CDMOFrom development to commercial realityHelping biopharmaceutical innovators build scalable, manufacturable, and commercially viable processes from the start. more ➔
autoimmune diseaseAATec is pioneering a new approach to lung diseasesAATec is advancing ATL-105, a new recombinant version of alpha-1 antitrypsin for inhalation, into clinical development for chronic respiratory diseases. Rüdiger Jankowsky, CEO, and Gabriele Matschiner, … more ➔
BiosimilarsPerfusion for next generation biosimilarsPerfusion is here, and it is rewriting the rules of biologics and biosimilar manufacturing. What was once experimental has become industrial reality: scalable, robust, regulatorily accepted, and commercially … more ➔
CRO & CDMOEvery process is different. Not the platform.For CDMOs, flexible upstream platforms can help streamline process development while maintaining reproducibility and continuity across scales. more ➔
CRO & CDMODesigning biologics for commercial successJustyna Adamczyk, Associate VP Integrated MS&T at Rezon Bio, discusses why integrating development and manufacturing strategies is key to improving late-stage efficiency and commercialization readin … more ➔
